- Mergers and Acquisitions
- Collaboration and Partnerships
- Health Economics
OncoC4 merged with AcroImmune
An all-stock transaction between OncoC4, a biopharmaceutical business in its late stages, and AcroImmune has been completed. OncoC4 strengthens its development by adding two critical drug candidates, AI-061, a PD-1/VEGF...
Align ENT + Allergy Expands into Michigan with New Partnership
Align ENT + Allergy (“Align”) has announced a significant partnership with Mid-Michigan ENT, a leading private practice based in East Lansing, Michigan. This strategic move marks Align’s entry into Michigan,...
Align ENT + Allergy Expands into Michigan with New Partnership
Align ENT + Allergy (“Align”) has announced a significant partnership with Mid-Michigan ENT, a leading private practice based in East Lansing, Michigan. This strategic move marks Align’s entry into Michigan,...
Latest
BiopharmaPfizer picks Triana Biomedicines to find Molecular Glues for Cancer
US pharmaceutical giant Pfizer announced a groundbreaking collaboration with Triana Biomedicines to develop Molecular Glue Degraders. The partnership aims to create multiple advanced therapies, including cancer. The...
Latest
MedTechNewVue and Konica Minolta Healthcare Form Strategic Partnership to Improve Radiology Workflow
Deal Overview NewVue, a leader in cloud-native radiology workflow solutions, has partnered with Konica Minolta Healthcare Americas to integrate NewVue’s EmpowerSuite Radiology Workflow Orchestrator with Konica Minolta’s...
Latest
Digital HealthAd Scientiam and Abata Therapeutics are working together on digital biomarkers.
Ad Scientiam has partnered with Abata Therapeutics to provide digital biomarker expertise for a Phase I clinical research of ABA-101, a potential treatment for progressive multiple sclerosis (MS). Ad Scientiam will use its...
Latest
Health EconomicsAlign ENT + Allergy Expands into Michigan with New Partnership
Align ENT + Allergy (“Align”) has announced a significant partnership with Mid-Michigan ENT, a leading private practice based in East Lansing, Michigan. This strategic move marks Align’s entry into Michigan,...
- Collaboration and Partnerships
- Reimbursement
Align ENT + Allergy Expands into Michigan with New Partnership
Align ENT + Allergy (“Align”) has announced a significant partnership with Mid-Michigan ENT, a leading private practice based in East Lansing, Michigan. This strategic move marks Align’s entry into Michigan,...
Sorry, No Posts Found
Latest
Contract ServicesNuream Partners with Clayton Sleep Institute to Transform Sleep Science and Wellness
Overview of the Deal:Nuream, a leader in sleep solutions, has announced a strategic partnership with the Clayton Sleep Institute. This collaboration aims to revolutionize sleep health by combining Nuream’s innovative...
Latest
Health & WellnessSOMAÍ Pharmaceuticals Expands Cannabis-Based Medicines to Ireland in Partnership with Georgelle
SOMAÍ Pharmaceuticals has partnered with Georgelle Pharmaceutical to introduce the most extensive range of cannabis-based medicines to Ireland. The partnership aims to provide Irish patients with high-quality cannabis-based...
- FDA
- EMA
- PMDA
- NMPA
FDA Action Update: Designations (19th September 2024)
Glycomine received FTD for GLM101 Glycomine, Inc. has received FDA Fast Track Designation for GLM101, a mannose-1-phosphate replacement therapy aimed at treating phosphomannomutase 2-congenital disorder of glycosylation...
Sorry, No Posts Found
MannKind Receives PMDA Clearance for Phase 3 Trial of Clofazimine Inhalation Suspension for NTM Lung Disease
MannKind Corporation has announced clearance from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to begin the Phase 3 clinical trial (ICoN-1) of its Clofazimine Inhalation Suspension for treating nontuberculous...
